TGF-ß1 and VEGF after fresh frozen bone allograft insertion in oral-maxillo-facial surgery

Histology and Histopathology

Volumn 25, Issue 4, 2010, Pages 463-471

  Rodella, L F ^a   Favero, G ^a   Boninsegna, R ^a,b   Borgonovo, A ^b   Rezzani, R ^a   Santoro, F ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone regeneration; Fresh Frozen Bone (FFB); TGF 1; VEGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BONE; BONE REGENERATION; BONE TRANSPLANTATION; CRYOPRESERVATION; FEMALE; HUMAN; MALE; MAXILLOFACIAL PROSTHESIS; MAXILLOFACIAL SURGERY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RADIOGRAPHY;

ADULT; BONE AND BONES; BONE REGENERATION; BONE TRANSPLANTATION; CRYOPRESERVATION; FEMALE; HUMANS; MALE; MAXILLOFACIAL PROSTHESIS; MAXILLOFACIAL PROSTHESIS IMPLANTATION; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950286076     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Adell R., Lekholm U., Rockier B. and Branemark P.I. (1981). A 15-year study of osseointegrated implants in the treatment of edentulous jaw. Int. J. Oral. Surg. 10, 387-416.
2. Aguirre Zorzano L.A., Rodríguez Tojo M.J. and Aguirre Urizar J.M. (2007). Maxillary sinus lift with intraoral autologous bone and B--tricalcium phosphate: histological and histomorphometric clinical study. Med.Oral. Patol. Oral. Cir. Bucal. 12, E532-E536.
3. Board T.N., Rooney P. and Kay P.R. (2008). Strain imparted during impaction grafting may contribute to bony incorporation an in vitro study of the release of bmp-7 from allograft. J. Bone Joint. Surg. Br. 90, 821-824.
4. Bostrom M.P.(1998). Expression of bone morphogenetic proteins in fracture healing. Clin. Orthop. Relat. Res. 355 Suppl, S116-S123.
5. Buma P., Donk S., Slooff T.J. and Schreurs W. (2001). Bone graft incorporation after reconstruction of bony defects with impacted morselized bone graft. Histology of animals and patients. Ortop. Traumatol. Rehabil. 3, 41-47.
6. Burchardt H. (1983). The biology of bone graft repair. Clin. Orthop. Relat. Res. 174, 28-42.
7. Campbell S.E. and Katawa L. (1997). Angiotensin II stimulated expression of trasforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J. Mol. Cell. Cardiol. 7, 1947-1958.
8. Centrella M., McCarthy T.L. and Canalis E. (1991). Trasforming growth factor-beta and remodeling of bone. J. Bone Joint. Surg. Am. 73, 1418-1428.
9. Chen Y-J., Wurtz T., Wang C-J., Kuo Y.R., Yang K.D., Huang H-C. and Wang F-S. (2004). Recruitment of mesenchymal stem cells and expression of TGF-,1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J. Orthop. Res. 22, 526-534.
10. Chua C.C., Hamdy R.C. and Chua B.H. (2000). Mechanism of transforming growth factor-beta1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. Biochim. Biophys. Acta 1497, 69-76.
11. D'Aloja E., Santi E. and Aprili G. (2008). Fresh frozen homologous bone in oral surgery: case reports. Cell. Tissue Bank. 9, 41-46.
12. Dagtekin G., Schiffer R., Klein B., Jahnen-Dechent W. and Zwadlo-Klarwasser G. (2003). Modulation of angiogenic functions in human macrophages by biomaterials. Biomaterials 24, 3395-3401.
13. De Biase A., Guerra F., Cipriano L., Lamazza L. and Tucci E. (2005). Subantral filling by deantigenated heterologous bone and immediate fixture placement. Minerva Stomatol. 54, 99-108.
14. de la Piedra C., Vicario C., de Acuna L.R., Garcia-Moreno C., Traba M.L., Arlandis S., Marco F. and Lopez-Duran L. (2008). Osteoinductive effect of bone bank allografts on human osteoblasts in culture. J. Orthop. Res. Soc. 26, 200-207.
15. Deckers M.M., Karperien M., van der Bent C., Yamashita T., Papapoulos S.E. and Löwik C.W. (2000). Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141, 1667-1674.
16. Dragoo M.R. and Sullivan H.C. (1973a). A clinical and histological evaluation of autogenous iliaca bone grafts in humans II. External root resoption. J. Periodontol. 44, 614-625.
17. Dragoo M.R. and Sullivan H.C. (1973b). A clinical and histological evaluation of autogenous iliaca bone grafts in humans I. Wound healing 2 to 8 months. J. Periodontol. 44, 599-613.
18. Dubois C.M., Blanchette F., Laprise M.H., Leduc R., Grondin F. and Seidah N.G. (2001). Evidence that furin is an authentic trasforming growth factor-beta1-converting enzyme. Am. J. Pathol. 158, 305-316.
19. Egli R.J., Wingenfeld C., Hölzle M., Hempfing A., Fraitzl C.R., Ganz R. and Leunig M. (2006). Histopathology of cryopreserved bone allo-and isografts: pretreatment with dimethyl sulfoxide. J. Invest. Surg. 19, 87-96.
20. Faiella R.A. (2007). Is human bone allograft safe for the management of alveolar defects? A primer for patient consent. J. Mass. Dent. Soc. 56, 18-20.
21. Geiger F., Bertram H., Berger I., Lorenz H., Wall O., Eckhardt C., Simank H.G. and Richter W. (2005). Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J. Bone Miner. Res. 20, 2028-2035.
22. Giannoudis P.V., Dinopoulos H. and Tsiridis E. (2005). Bone substitutes: an update. Injury 36 (Suppl 3), S20-S27.
23. Gulaldi N.C.M., Shahlafar J., Makhsoosi M., Caner B., Araz K. and Erbengi G. (1998). Scintigraphic evaluation of healing response after heterograft usage for alveolar extraction cavity. Oral. Surg. Oral. Med.Oral. Pathol. Oral. Radiol. Endod. 85, 520-525.
24. Hardesty R.A. and Marsh J.L. (1990). Craniofacial onlay bone grafting: a prospective evaluation of morphology, orientation and embryonic origin. Plast. Reconstr. Surg. 85, 4-14.
25. Hatano N., Shimizu Y. and Ooya K. (2004). A clinical long-term radiographic evaluation of graft height changes after maxillary sinus floor augmentation with a 2:1 autogenous bone/xenograft mixture and simultaneous placement of dental implants. Clin. Oral. Implants Res. 15, 339-345.
26. Hauschka P.V., Chen T.L. and Mavrakos A.E. (1988). Polypeptide growth factors in bone matrix. Ciba Found. Symp. 136, 207-225.
27. Heyligers I.C. and Klein-Nulend J. (2005). Detection of living cells in non-processed but deep-frozen bone allografts. Cell. Tissue Bank. 6, 25-31.
28. Hollinger J.O., Brekke J., Gruskin E. and Lee D. (1996). Role of bone substitutes. Clin. Orthop. Relat. Res. 324; 55-65. Erratum in: Clin. Orthop. 324, 55-65.
29. Huebsch R.F. and Hansen L.S. (1969). A histopathologic study of extraction wounds in dogs. Oral Surg. Oral. Med. Oral. Pathol. 28, 187-196.
30. Joyce M.E., Jingushi S. and Bolander M.E. (1990). Transforming growth factor-beta in the regulation of fracture repair. Orthop. Clin. North. Am. 21, 199-209.
31. Joyce M.E., Roberts A.B., Sporn M.B. and Bolander M.E. (1990). Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110, 2195-2207.
32. Kao S.T. and Scott D.D. (2007). A review of bone substitutes. Oral. Maxillofacial. Surg. Clin. N. Am. 19, 513-521.
33. Kleinheinz J., Stratmann U., Joos U. and Wiesmann H.P. (2005). VEGF-activated angiogenesis during bone regeneration. J. Oral. Maxillofac. Surg. 63, 1310-1316.
34. KöndeN P.A., Mattsson T. and Astrand P. (1996). Immunological responses to maxillary on-lay allogeneic bone grafts. Clin. Oral. Implants Res. 7, 373-377.
35. Labanca M., Leonida A. and Rodella L.F. (2008). Biomateriali naturali di sintesi in odontoiatria: scienza ed etica come criteri per la loro scelta. Implantologia-La rivista per il clinico; 1/108 Anno 6, Quintessenza edizioni.
36. Lalani Z., Wong M., Brey E.M. and Mikos A.G. (2003). Spatial and temporal localization of transforming growth factor-,1, bone morphogenetic protein-2, and platelet-derived groth factor-A in healing tooth extraction sockets in a rabbit model. J. Oral. Maxillofac. Surg. 61, 1061-1072.
37. Lalani Z., Wong M., Brey E.M., Mikos A.G., Duke P.J., Miller J.M., Johnston C. and Montufar-Solis D. (2005). Spatial and temporal localization of FGF-2 and VEGF in healing tooth extraction sockets in rabbit model. J. Oral. Maxillofac. Surg. 63, 1500-1508.
38. Listgarten M.A. and Rosenberg M.M. (1979). Histological study of repair following new attachment procedures in human periodontal lesion. J. Periodontol. 50, 333-344.
39. Mori S., Akagi M., Kikuyama A., Yasuda Y. and Hamanishi C. (2006). Axial shortening during distraction osteogenesis leads to enhanced bone formation in rabbit model through the HIF-1./vascular endothelial growth factor system. J. Orthop. Res. 24, 653-663.
40. Orgill D. and Demling R.H. (1988). Current concepts and approaches to wound healing. Crit. Care Med. 16, 899-908.
41. Ozkan K., Eralp L., Kocaoglu M., Ahishali B., Bilgic B., Mutlu Z., Turker M., Ozkan F.U., Sahin K. and Guven M. (2007). The effect of trasforming growth factor ß1 (TGF-ß1) on the regenerate bone in distraction osteogenesis. Growth Factors 25, 101-107.
42. Perrott D.H., Smith R.A. and Kaban L.B. (1992). The use of fresh frozen allogeneic bone for maxillary and mandibular reconstruction. Int. J. Oral. Maxillofac. Surg. 21, 260-265.
43. Rawashdeh M.A. and Telfah H. (2008). Secondary alveolar bone grafting: the dilemma of donor site selection and morbidity. Br. J. Oral. Maxillofac. Surg. 46, 665-670.
44. Ripamonti U. and Duneas N. (1998). Tissue morphogenesis and regeneration by bone morphogenetic proteins. Plast. Reconstr. Surg. 101, 227-239.
45. Sanz Casado J.V. (2002). Bone regeneration in oral surgery. An. R. Acad. Nac. Med. 119, 237-254.
46. Simion M. and Fontana F. (2004). Autogenous and xenogeneic bone grafts for the bone regeneration-A literature review. Minerva Stomatol. 53, 191-206.
47. Simpson D., Kakarala G., Hampson K., Steele N. and Ashton B. (2007). Viable cells survive in fresh frozen human bone allografts. Acta Orthop. 78, 26-30.
48. Stacchi C., Orsini G., Di Iorio D., Breschi L. and Di Lenarda R. (2008). Clinical, histologic, and histomorphometric analysis of regenerated bone in maxillary sinus augmentation using fresh frozen human bone allografts. J. Periodontol. 79, 1789-1796.
49. Sun Y., Zhang W., Ma F., Chen W. and Hou S. (1997). Evaluation of transforming growth factor beta and bone morphogenetic protein composite on healing of bone defects. Chin. Med. J. (Engl) 110, 927-931.
50. Takeuchi T. and Shidou T. (1993). Impairment of blood supply to the head of the femur after fracture of the neck. Int. Orthop. 17, 325-329.
51. Tanaka S., Matsuzaka K., Sato D. and Inoue T. (2007). Characteristics of newly formed bone during guided bone regeneration: analysis of cbfa-1, osteocalcin and VEGF expression. J. Oral. Implantol. 33, 321-326.
52. van Biezen F.C., ten Have B.L. and Verhaar J.A. (2000). Impaction bone-grafting of severely defective femora in revision total hip surgery: 21 hips followed for 41-85 months. Acta Orthop. Scand. 71, 135-142.
53. Weyts F.A., Bos P.K., Dinjens W.N., van Doorn W.J., van Biezen F.C., Weinans H. and Verhaar J.A. (2003). Living cells in 1 of 2 frozen femoral heads. Acta Orthop. Scand. 74, 661-664.
54. Wong M.E., Hollinger J.O. and Pinero G.J. (1996). Integrated processes responsible for soft tissue healing. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 82, 475-492.
55. Zimmermann G., Henle P., Kusswetter M., Moghaddam A., Wetzensen A., Richter W. and Weiss S. (2005). TGF-ß1 as a marker of delayed fracture healing. Bone 36, 779-785.